gadobutrol
- Product NDC
- 70710-2066
- Requested package NDC
- 70710-2066-6
- 11-digit product format
- 707102066
- Labeler code
- 70710
- Product ID
- 70710-2066_4bdf7135-c236-4892-96e0-db2d78d53853
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- gadobutrol
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Application
- ANDA219287
- Marketing category
- ANDA
- Marketing start
- 2026-07-14
- Substance
- GADOBUTROL
- Active strength
- 604.72 mg/mL
- Pharmacologic classes
- Gadolinium-based Contrast Agent [EPC]; Magnetic Resonance Contrast Activity [MoA]
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219287-001 | GADOBUTROL | GADOBUTROL | 4.5354GM/7.5ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-06-11 | |
| A219287-002 | GADOBUTROL | GADOBUTROL | 6.0472GM/10ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-06-11 | |
| A219287-003 | GADOBUTROL | GADOBUTROL | 9.0708GM/15ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-06-11 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219287-001 | AP |
| A219287-002 | AP |
| A219287-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219287-001 | GADOBUTROL | 4.5354GM/7.5ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-06-11 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219287-002 | GADOBUTROL | 6.0472GM/10ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-06-11 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219287-003 | GADOBUTROL | 9.0708GM/15ML (604.72MG/ML) | SOLUTION / INTRAVENOUS | AP | 2026-06-11 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219287-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219287-002 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219287-003 | AP | 1 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- gadobutrol
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GADOBUTROL | 604.72 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1BJ477IO2L | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4ea8ae43-22ca-40c0-be72-c91a321cafd1 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| gadobutrol | GADOBUTROL | Zydus Pharmaceuticals USA Inc. | 4ea8ae43-22ca-40c0-be72-c91a321cafd1 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | 219287 ANDA219287 70710-2066-6 70710-2066 70710206606 |
| gadobutrol | GADOBUTROL | Viwit Pharmaceutical Co., Ltd. | 18c67a70-0c1f-46d4-a123-66080090b71b | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | 219287 ANDA219287 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Status |
|---|---|---|---|---|---|
| 70710-2066-6 | 70710206606 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70710-2066-6) / 15 mL in 1 VIAL, SINGLE-DOSE (70710-2066-1) | 2026-07-14 | 0 | Current |